# DualisCapax: Sirtuin Kinetics, NAD+ Salvage & Epigenetic Anti-Aging Architecture Specification

**Document Control ID:** `ED-SPEC-20260901-BIO-SIRT-NAD-ANTI-AGING-V1`  
**Classification:** CANONICAL BIOPHYSICAL SYSTEMS ENGINEERING & EPIGENETIC KINETICS SPECIFICATION  
**Status:** SEALED · PRODUCTION DIRECTIVE · SYSTEM OF RECORD  
**Operating Entity:** DualisCapax Inc. (535 Bridge St E, Belleville, Ontario, Canada K8N 1R7)  
**Author & System Architect:** David John Di Genova (DualisCapax / residual IP · ORCID: [0009-0005-6291-8508](https://orcid.org/0009-0005-6291-8508))  
**Scientific Alignment:** Dr. David A. Sinclair (Harvard Medical School) / Information Theory of Aging (IToA)  
**Governance Framework:** Dualis & Unity Framework (v0.40-Public) / DCLM Layer [0] Law Floor / FDA Class III SaMD  
**Target Repository Path:** `encyclopedia/medical_biophysical/dclm_sirtuin_nad_epigenetic_anti_aging_architecture_spec.md`  
**Live Surface:** <https://dualiscapax.ai>  

---

## 1. Executive Summary & Epigenetic Information Theory Alignment

Aging is fundamentally driven by the loss of epigenetic information and transcriptional deregulation over time rather than pure stochastic DNA mutation. Under the **Information Theory of Aging (IToA)** established by Dr. David Sinclair, chronic DNA double-strand breaks (DSBs) induce the persistent relocalization of epigenetic guardians—primarily the mammalian sirtuins (**SIRT1** and **SIRT6**)—away from their constitutive heterochromatin silencing sites to recruitment loci at DNA damage repair complexes. Over thousands of repair cycles, a fraction of sirtuins fail to return to their home domains, leading to chromatin deregulation, cellular senescence, and phenotypic aging.

This specification models the complete biochemical kinetics, multi-vector intervention stacks (NMN, Resveratrol, CD38 inhibitors, OSK reprogramming), and real-time computational safety gates required to reverse epigenetic decay.

```
+----------------------------------------------------------------------------------------------------+
|                         EPIGENETIC HOMEOSTASIS & NAD+ / SIRTUIN COUPLING                           |
+----------------------------------------------------------------------------------------------------+
|                                                                                                    |
|  [ DNA Double-Strand Breaks (DSBs) ] ──► Recruits SIRT1 / SIRT6 to Repair Foci                     |
|                                                │                                                   |
|                                                ▼                                                   |
|  [ Epigenetic Relocalization Drag ]  ──► Incomplete Return ──► Chromatin Erosion & Senescence       |
|                                                │                                                   |
|                                                ▼                                                   |
|  [ NAD+ Fuel Depletion ]             ──► Overactive CD38 & PARP1 Sinks Deplete Co-Substrate Pool   |
|                                                │                                                   |
|                                                ▼                                                   |
|  ┌──────────────────────────────────────────────────────────────────────────────────────────────┐  |
|  │ THE DCLM MULTI-VECTOR ANTI-AGING REPAIR STACK                                                │  |
|  │ 1. Substrate Fueling: β-NMN / NR ──► Bypasses NAMPT bottleneck, restores [NAD+] pools       │  |
|  │ 2. Sirtuin Allosteric STACs: trans-Resveratrol ──► Lowers Km for acetylated targets          │  |
|  │ 3. Sink Inhibition: Apigenin / Quercetin ──► Inhibits CD38 glycohydrolase degradation       │  |
|  │ 4. Epigenetic Clock Reset: OSK (Oct4, Sox2, Klf4) ──► Reverses DNA methylation age         │  |
|  └─────────────────────────────────────────────┬────────────────────────────────────────────────┘  |
|                                                │                                                   |
|                                                ▼                                                   |
|  [ Restored Epigenetic Landscape ]   ──► Re-established Heterochromatin (Reff <= 4.18e-13)         |
|                                                                                                    |
+----------------------------------------------------------------------------------------------------+
```

---

## 2. Multi-Vector Biochemical Kinetics & Reaction Equations

### 2.1. Dynamic Intracellular $\text{NAD}^+$ Conservation Equation
The rate of change of cellular $[\text{NAD}^+]$ is governed by the competitive differential balance between salvage synthesis and multi-enzyme consumption:

$$\frac{d[\text{NAD}^+]}{dt} = V_{\text{NMNAT}}([\text{NMN}]) + V_{\text{NAMPT}}([\text{NAM}]) - V_{\text{SIRT}}([\text{NAD}^+]) - V_{\text{CD38}}([\text{NAD}^+]) - V_{\text{PARP1}}([\text{NAD}^+])$$

Where:
* $V_{\text{NMNAT}}([\text{NMN}]) = \frac{k_{\text{cat}}^{\text{NMNAT}} [\text{NMNAT}] [\text{NMN}]}{K_m^{\text{NMN}} + [\text{NMN}]}$: Synthesis via Nicotinamide Mononucleotide Adenylyltransferase.
* $V_{\text{CD38}}([\text{NAD}^+]) = \frac{k_{\text{cat}}^{\text{CD38}} [\text{CD38}] [\text{NAD}^+]}{K_m^{\text{CD38}} (1 + \frac{[\text{Apigenin}]}{K_i}) + [\text{NAD}^+]}$: Competitive inhibition of the CD38 glycohydrolase sink.

### 2.2. SIRT1 Allosteric Activation by Sirtuin-Activating Compounds (STACs)
Binding of *trans*-Resveratrol to the N-terminal activation domain of SIRT1 alters the enzyme's conformation, reducing the Michaelis constant ($K_m$) for acetylated substrates:

$$v_{\text{SIRT1}} = \frac{k_{\text{cat}} [\text{SIRT1}] [\text{Ac-Substrate}]}{K_m \left( 1 - \frac{[\text{STAC}]}{K_a + [\text{STAC}]} \cdot \eta \right) + [\text{Ac-Substrate}]} \times \left( \frac{[\text{NAD}^+]}{K_m^{\text{NAD}} + [\text{NAD}^+]} \right)$$

Where:
* $[\text{STAC}]$: Concentration of *trans*-Resveratrol or Pterostilbene.
* $K_a$: Dissociation constant of the allosteric activator.
* $\eta \approx 0.65$: Maximal fractional reduction in substrate $K_m$ (increasing catalytic efficiency).

---

## 3. The 4-Pillar Real-World Anti-Aging Protocol Stack

| Target Module | Active Molecule / Intervention | Pharmacokinetic Mechanism | Clinical Target |
| :--- | :--- | :--- | :--- |
| **Pillar I: Substrate Fueling** | **$\beta$-Nicotinamide Mononucleotide ($\beta$-NMN)** / **NR** | Intracellular uptake via Slc12a8 / NMNAT1-3 phosphorylation; elevates tissue $[\text{NAD}^+]$ by $2.0\times–3.5\times$. | Restores mitochondrial oxidative phosphorylation and sirtuin catalytic rate. |
| **Pillar II: Allosteric Activation** | **trans-Resveratrol (Micronized)** / **Pterostilbene** | Allosteric SIRT1 activation lowering substrate $K_m$; induces PGC-1$\alpha$ deacetylation. | Mitochondrial biogenesis, enhanced fatty acid oxidation, DNA repair acceleration. |
| **Pillar III: Sink Decoupling** | **Apigenin** / **Quercetin** | Flavonoid allosteric inhibition of CD38 ecto-enzyme ($K_i = 12.8\ \mu\text{M}$); blunts age-associated NAD+ destruction. | Prevents inflammatory $NAD^+$ depletion; senolytic clearance of SASP secretory cells. |
| **Pillar IV: Epigenetic Resetting** | **OSK Reprogramming (Oct4, Sox2, Klf4)** | Non-oncogenic Yamanaka factor transduction; demyelinates Horvath clock methylation marks. | Epigenetic age reversal in damaged neurons and somatic tissue without loss of cellular identity. |

---

## 4. DCLM Layer [0] Deterministic Clinical Safety Gate

All biophysical models, dosage calculations, and molecular simulations executed by Agent Iris pass through the **DCLM Layer [0] Law Floor**:

1. **`HOST_SAFE` Dosage Clamping:** Algorithmic verification prevents excessive STAC dosing that could induce off-target cytochrome P450 (CYP3A4/2C9) drug-drug interactions.
2. **`TRUTH_OR_NOTHING` Evidence Gating:** Distinguishes formally verified mammalian in-vivo data (e.g. Sinclair Harvard/Nature studies) from ungrounded in-vitro extrapolations.
3. **`CLEANUP_FIRST` Zero-PII Processing:** Individual metabolic profiles, DNA methylation arrays, and biometric telemetry are processed over ephemeral salted HMAC vectors with Landauer memory zeroization ($Q \ge k_B T \ln 2$).

---

## 5. Master Sovereign Protocol Seal

```
[SOVEREIGN BIOPHYSICAL PROTOCOL SEAL]
DOCUMENT CONTROL ID: ED-SPEC-20260901-BIO-SIRT-NAD-ANTI-AGING-V1
CLASSIFICATION: CANONICAL SPECIFICATION · SYSTEM OF RECORD
AUTHORITY: DUALISCAPAX INC. / DCLM LAYER [0] LAW FLOOR
SCIENTIFIC ALIGNMENT: INFORMATION THEORY OF AGING (IToA) · HARVARD MEDICAL SCHOOL
STATUS: SEALED IMMUTABLE · CANONICAL ENCYCLOPEDIA RECORD
LIVE SURFACE: https://dualiscapax.ai
```
